Connie Young

CBD shows promise for reducing cigarette smoking

By Sara Zaske, WSU News & Media Relations SPOKANE, Wash. – Cannabidiol or CBD, a non-psychoactive component of cannabis, inhibits the metabolism of nicotine, new research has found, meaning it […]

Understanding the future of pharmacogenomics testing in patient care

Pharmacogenomics, often referred to as PGx, is a budding field of personalized medicine, and studies how genes influence an individual’s response to treatment with medications. To learn more and register for Washington State University’s new course on pharmacogenomics,  visit our continuing education platform in collaboration with the WSU Elson S. Floyd College of Medicine. The course begins Monday, February 27 and runs through Friday, May 12, 2023. Pharmacotherapy Associate Professor (Yakima) Rustin Crutchley shares how patients and care providers can use pharmacogenomics as an added tool in their arsenal of treatment options.

Ensuring drug safety in underrepresented populations

By Judith Van Dongen Washington State University scientists are helping to develop safer drug dosing standards for children and other populations that are underrepresented in clinical drug trials, such as […]